Marrone Bio Innovations Profit Margin

Marrone Bio Innovations (MBII) currently reports a profit margin of -47.08% as of March 2022. That compares with -37.94% in the prior-year period — down 24.1% year over year. That is below the Materials sector average of 16.96%. Use the charts on this page to explore Marrone Bio Innovations's profit margin history and peer comparisons.

Marrone Bio Innovations's profit margin decreased from -37.94% to -47.08% — a 24.1% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Marrone Bio Innovations's profit margin of -47.08% is lower than the Materials sector average of 16.96%. That is roughly 377.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Marrone Bio Innovations's current -47.08% should be judged against Materials norms (sector average: 16.96%) and against MBII's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -47.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 16.96%. From there, open related valuation or income-statement pages for Marrone Bio Innovations, and consider following MBII for alerts when major investors trade the stock.